Tirofiban Hydrochloride
Tirofiban Hydrochloride is listed in the FDA National Drug Code directory with 6 NDC codes, marketed under brand name including Tirofiban Hydrochloride. Available dosage forms: injection, solution, injection, powder.
Drug Details
- Generic Name
- Tirofiban Hydrochloride
- Brand Names
- Tirofiban Hydrochloride
- Application Number
- ANDA206888
- Sponsor
- Sagent Pharmaceuticals
- NDC Codes
- 6
- Dosage Forms
- INJECTION, SOLUTION, INJECTION, POWDER
- Routes
- INTRAVENOUS
- Active Ingredients
- TIROFIBAN HYDROCHLORIDE
Indications and Usage
1 INDICATIONS AND USAGE Tirofiban hydrochloride injection is indicated to reduce the rate of thrombotic cardiovascular events (combined endpoint of death, myocardial infarction, or refractory ischemia/repeat cardiac procedure) in patients with non-ST elevation acute coronary syndrome (NSTE-ACS). Tirofiban hydrochloride injection is a platelet aggregation inhibitor indicated to reduce the rate of thrombotic cardiovascular events (combined endpoint of death, myocardial infarction, or refractory ischemia/repeat cardiac procedure) in patients with non-ST elevation acute coronary syndrome (NSTE-ACS). ( 1 )